Cardio Diagnostics Holdings, Inc.

CDIO Nasdaq SEC CIK 1870144
Follow Cardio Diagnostics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $3.6K +25.7% vs same quarter last year
Net income −$1.7M −1% vs same quarter last year
EPS, diluted −$0.59 +39.8% vs same quarter last year
Operating cash flow −$1.5M −8.8% vs same quarter last year
Revenue by quarter
$4.5K
$940
$7.5K
$2.9K
$3.6K
$2.7K
$5.4K
$3.6K
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income6 fiscal years
  • Revenue
  • Net income
−$10M−$7.5M−$5M−$2.5M$0$2.5MFY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$14.8K−$6.5M
FY24$34.9K−$8.4M
FY23$17.1K−$8.4M
FY22$950−$4.7M
FY21$901−$620.4K
FY20--
MarginsShare of revenue
  • Operating margin
  • Net margin
−600000%−400000%−200000%0%FY20FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY25−43737.5%−43832.5%
FY24−23977.9%−24028.2%
FY23−42440.4%−49087.8%
FY22−478784.3%−490630%
FY21−68862.2%−68862.2%
FY20--
Free cash flowOperating cash flow minus capital expenditure
−$8M−$6M−$4M−$2M$0FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$5.9M
FY24−$5.2M
FY23−$6.2M
FY22-
FY21-
FY20-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Cardio Diagnostics
  • Healthcare median
−600000%−400000%−200000%0%FY20FY21FY22FY23FY24FY25
Show the numbers
YearCardio DiagnosticsHealthcare median
FY25−43832.5%−30.6%
FY24−24028.2%−47%
FY23−49087.8%−58%
FY22−490630%−80.4%
FY21−68862.2%−71.9%
FY20-−62.2%